6505--Supply, Axumin-Axumin + Cerianna Medicines - Nuclear Med, CLE
ID: 36C25024Q1072Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF250-NETWORK CONTRACT OFFICE 10 (36C250)DAYTON, OH, 45428, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/5423a573b1184685b1c263cdafe31c84/view
Timeline
    Description

    The Department of Veterans Affairs intends to solicit and negotiate exclusively with PetNet Solutions and TrillaMed for the supply of three proprietary radiopharmaceuticals—Axumin, Amyvid, and Cerianna—for the Nuclear Medicine Service at the Louis Stokes Cleveland VA Medical Center. These products are critical for diagnosing recurrent prostate cancer, breast cancer, and Alzheimer’s disease, necessitating the use of a local radiopharmacy due to their radioactive nature and short shelf life. Interested vendors may submit their capabilities until September 18, 2024, to determine if a competitive procurement process is feasible, with all inquiries directed to Contract Specialist Don Caldwell at don.caldwell@va.gov.

    Point(s) of Contact
    Gina P. CrankContracting Officer
    (614) 625-1236
    NA
    gina.crank@va.gov
    Files
    Title
    Posted
    S02 RFQ 36C25024Q1072 Intent to Sole Source Final.docx
    The Department of Veterans Affairs intends to solicit and negotiate exclusively with PetNet Solutions and TrillaMed for the supply of three proprietary radiopharmaceuticals—Axumin, Amyvid, and Cerianna—for the Nuclear Medicine Service at the Louis Stokes Cleveland VA Medical Center. These products are essential for diagnosing recurrent prostate cancer, breast cancer, and Alzheimer’s disease, respectively. Due to their radioactive nature and short shelf life, a local radiopharmacy is required, making these specific suppliers the only responsible sources meeting agency needs under FAR 6.302-1(a)(2). Input from other interested vendors is welcomed until September 18, 2024, as the VA evaluates if a competitive procurement process may be appropriate. All inquiries should be directed to Contract Specialist Don Caldwell via email. This notice emphasizes the limited competition rationale and the urgency of securing specialized medical supplies critical for patient diagnostics.
    Lifecycle
    Title
    Type
    6505--Supply, Axumin-Axumin + Cerianna Medicines - Nuclear Med, CLE
    Currently viewing
    Special Notice
    Similar Opportunities
    6505--Notice of Intent to Sole Source Pluvicto and Lutathera
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole source contract to Advanced Accelerator Applications USA for the provision of Pluvicto and Lutathera, specialized radiopharmaceuticals used in the treatment of metastatic castration-resistant prostate cancer and gastroenteropancreatic neuroendocrine tumors. This procurement is justified under FAR regulations due to the unique and highly specialized nature of the therapies required, which limits the availability of suitable suppliers. Interested parties are invited to submit their capability statements, including qualifications and relevant contract information, by 10:00 AM PT on September 25, 2024, to Peter Kim at peter.kim33@va.gov. The contracting office is located in Long Beach, CA, and responses must be submitted electronically; failure to respond may result in the contract being awarded without further solicitation.
    Q522--PHARMACUTICAL, STL 657-24-3-1642-0121, (VA-25-00001168)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking responses to a Sources Sought Notice for a contract involving the provision of a proprietary radiopharmaceutical agent, Pluvicto, for the St. Louis VA Medical Center. This contract will cover a base year plus four option years for the supply of Lutetium LU 177 Vipivvotide Tetraxetan, which is critical for treating adult patients with prostate-specific membrane antigen (PSMA) positive metastatic castration-resistant prostate cancer. The selected contractor will be responsible for administering this radioactive diagnostic therapy via IV, with all contract administration functions retained by the Department of Veterans Affairs. Interested parties must submit their responses by September 20, 2024, at 3:00 PM CST, to Michael P. Murphy at michael.murphy7@va.gov, including their Unique Entity ID and relevant qualifications.
    Q527--Intent to Sole Source Radiopharm Isotopes-Wilkes-Barre VAMC
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through Network Contracting Office 4, intends to issue a sole source contract for the provision of Radiopharmaceutical Isotopes to the Wilkes-Barre VA Medical Center, specifically with Jubilant Draximage Radiopharmaceuticals Inc. The contract aims to ensure the timely delivery of radiopharmaceuticals that comply with U.S. Nuclear Regulatory Commission (NRC) and Food and Drug Administration (FDA) regulations, thereby prioritizing patient safety and effective healthcare for veterans. This procurement is critical for maintaining high-quality medical services, as the contractor will be required to adhere to strict quality control measures, provide emergency services, and ensure proper packaging and labeling of all materials supplied. Interested vendors must submit a capability statement by September 20, 2024, to the Contracting Specialist, Christa Stine, at christa.stine@va.gov.
    6505--Lymphoseek IDIQ
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 22, intends to award a Sole Source contract for the procurement of Lymphoseek, a proprietary radiopharmaceutical, primarily for use at the VA Loma Linda Healthcare System. This contract, designated as Solicitation Number 36C26225Q0026, will be structured as a Firm Fixed-Price Indefinite Quantity Indefinite Delivery (IDIQ) with a base year and four option years, with an estimated quantity of 86 study doses required annually. Lymphoseek is critical for identifying sentinel lymph nodes in melanoma patients, providing superior image quality due to its targeted action on the CD206 receptor. Interested parties may submit a capabilities statement by September 27, 2024, at 10:00 AM Pacific Time, and should direct inquiries to Hestia Sim at Hestia.Sim@va.gov.
    6505--Ga68 PSMA Injection (Illucix)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking a contractor to provide Gallium Ga68 (Ga68-PSMA; Illucix®) radiopharmaceutical injections for the VA North Texas Health Care System, with a focus on PET imaging of prostate cancer lesions. The procurement requires contractors to possess a valid license from the US Nuclear Regulatory Commission and adhere to federal and state regulations regarding the handling and transportation of radioactive materials, ensuring safe and efficient delivery of essential medical supplies. Interested parties must submit their quotations by October 8, 2024, at 3:00 PM CST, to the designated Contract Specialist, Vance Farrell, via email, with the anticipated delivery period set from October 25, 2024, to October 24, 2025.
    6505--Abiraterone Acetate Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting offers for the supply of Abiraterone Acetate tablets, a pharmaceutical product critical for various government healthcare facilities, including the VA and DoD. The procurement aims to establish a reliable source through competitive contracting, requiring offerors to provide pricing for a base year and four option years, along with an NDC number for their products. Abiraterone Acetate is essential for treating specific cancers, underscoring the importance of ensuring consistent availability of this medication to support patient care. Interested vendors should contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further details, and must comply with specific packaging, labeling, and manufacturing standards as outlined in the solicitation document.
    6515--***EMERGENCY*** 36C242-24-AP-4714 | 528-24-4-8085-0159 Sun Nuclear Map Check - Radiation Oncology equipment Sole-Source Notice
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to award a sole-source contract to Sun Nuclear for specialized radiation oncology equipment necessary for measuring radiation plans in brain treatment. The procurement includes critical devices such as the SRS MapCheck for stereotactic quality assurance, a StereoPHAN package for comprehensive testing, and a MultiMet WL Cube for assessing off-axis accuracy, along with a one-day on-site training session for proper equipment usage. This equipment is vital for ensuring precision in stereotactic radiation therapy, which is essential for effective patient treatment outcomes. The total funding amount for this procurement is $93,270, and interested parties should note that the response deadline is September 24, 2024, with no quotes being accepted due to the sole-source nature of the contract. For further inquiries, contact Corey Swinton, the Contracting Officer, at Corey.Swinton@va.gov.
    Teleradiology Services for VASNHCS
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for Teleradiology Services for the Veterans Affairs Southern Nevada Health Care System (VASNHCS). The contract requires certified or board-eligible radiology physicians to provide remote diagnostic imaging services, including CT, MRI, and ultrasound scans, in accordance with strict American College of Radiology standards. This procurement is critical for ensuring timely and accurate diagnostic services for veterans, with an estimated total contract value of $19 million over the performance period from December 1, 2024, to November 30, 2029. Interested vendors should contact Maricela A Berrones-Gauger at maricela.berrones-gauger@va.gov for further details and to submit proposals, adhering to the Service-Disabled Veteran-Owned Small Business (SDVOSB) set-aside requirements.
    6525--Brand Name or Equal to Ethicon NeuWave Certus 140 microwave Ablation System. Unrestricted.
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the acquisition of a "Brand Name or Equal" Ethicon NeuWave Certus 140 Microwave Ablation System, intended for use in the Interventional Radiology department at the Corporal Michael J. Crescenz VA Medical Center. This advanced medical system is designed to enhance treatment options for veterans suffering from cancer or benign tumors through minimally invasive procedures, featuring capabilities such as simultaneous use of multiple ablation probes and a CO2-based cooling system. The procurement emphasizes adherence to Federal Acquisition Regulation (FAR) clauses and requires vendors to submit their quotes by September 20, 2024, with evaluations based on price and technical acceptability. Interested vendors can reach out to Contracting Officer David M Santiago at david.santiago2@va.gov for further information.
    Q522--Teleradiology Physician Services - VANEOHS
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking Teleradiology Physician Services for the Northeast Ohio Healthcare System (VANEOHS) to provide 24/7 interpretations of Diagnostic Imaging procedures, along with in-house IT support. This procurement will consist of five one-year ordering periods, reflecting the VA's commitment to enhancing healthcare delivery through specialized remote radiology services. The solicitation for these services is expected to be available on or about September 20, 2024, with a response deadline set for October 18, 2024, at 2:00 PM Eastern Time. Interested parties can contact Contracting Specialist Karen Williams at Karen.Williams4@va.gov or by phone at 614-257-5220 for further details.